| Variable . | ccRCC, N = 931 . | RMC, N = 871 . | P-value2 . |
|---|---|---|---|
| Age | 60.00 (35.00-78.00) | 29.00 (14.00-67.00) | <.001 |
| Race | <.001 | ||
| Black | 6/93 (6.5%) | 70/87 (80%) | |
| White | 76/93 (82%) | 9/87 (10%) | |
| Other | 11/93 (12%) | 8/87 (9.2%) | |
| Ethnicity | .028 | ||
| Not Hispanic | 75/93 (81%) | 80/87 (92%) | |
| Hispanic | 18/93 (19%) | 7/87 (8.0%) | |
| Gender | .014 | ||
| Male | 75/93 (81%) | 56/87 (64%) | |
| Female | 18/93 (19%) | 31/87 (36%) | |
| Sickle hemoglobinopathies | <.001 | ||
| None | 91/91 (100%) | 7/86 (8.1%) | |
| Sickle cell trait | 0/91 (0%) | 76/86 (88.4%) | |
| Sickle cell disease | 0/91 (0%) | 1/86 (1.2%) | |
| Sickle cell beta thalassemia | 0/91 (0%) | 2/86 (2.3%) | |
| Unknown | 0/91 (0%) | 1 |
| Variable . | ccRCC, N = 931 . | RMC, N = 871 . | P-value2 . |
|---|---|---|---|
| Age | 60.00 (35.00-78.00) | 29.00 (14.00-67.00) | <.001 |
| Race | <.001 | ||
| Black | 6/93 (6.5%) | 70/87 (80%) | |
| White | 76/93 (82%) | 9/87 (10%) | |
| Other | 11/93 (12%) | 8/87 (9.2%) | |
| Ethnicity | .028 | ||
| Not Hispanic | 75/93 (81%) | 80/87 (92%) | |
| Hispanic | 18/93 (19%) | 7/87 (8.0%) | |
| Gender | .014 | ||
| Male | 75/93 (81%) | 56/87 (64%) | |
| Female | 18/93 (19%) | 31/87 (36%) | |
| Sickle hemoglobinopathies | <.001 | ||
| None | 91/91 (100%) | 7/86 (8.1%) | |
| Sickle cell trait | 0/91 (0%) | 76/86 (88.4%) | |
| Sickle cell disease | 0/91 (0%) | 1/86 (1.2%) | |
| Sickle cell beta thalassemia | 0/91 (0%) | 2/86 (2.3%) | |
| Unknown | 0/91 (0%) | 1 |
1Median (range); n/N (%).
2Wilcoxon rank sum test; Pearson’s chi-squared test.
| Variable . | ccRCC, N = 931 . | RMC, N = 871 . | P-value2 . |
|---|---|---|---|
| Age | 60.00 (35.00-78.00) | 29.00 (14.00-67.00) | <.001 |
| Race | <.001 | ||
| Black | 6/93 (6.5%) | 70/87 (80%) | |
| White | 76/93 (82%) | 9/87 (10%) | |
| Other | 11/93 (12%) | 8/87 (9.2%) | |
| Ethnicity | .028 | ||
| Not Hispanic | 75/93 (81%) | 80/87 (92%) | |
| Hispanic | 18/93 (19%) | 7/87 (8.0%) | |
| Gender | .014 | ||
| Male | 75/93 (81%) | 56/87 (64%) | |
| Female | 18/93 (19%) | 31/87 (36%) | |
| Sickle hemoglobinopathies | <.001 | ||
| None | 91/91 (100%) | 7/86 (8.1%) | |
| Sickle cell trait | 0/91 (0%) | 76/86 (88.4%) | |
| Sickle cell disease | 0/91 (0%) | 1/86 (1.2%) | |
| Sickle cell beta thalassemia | 0/91 (0%) | 2/86 (2.3%) | |
| Unknown | 0/91 (0%) | 1 |
| Variable . | ccRCC, N = 931 . | RMC, N = 871 . | P-value2 . |
|---|---|---|---|
| Age | 60.00 (35.00-78.00) | 29.00 (14.00-67.00) | <.001 |
| Race | <.001 | ||
| Black | 6/93 (6.5%) | 70/87 (80%) | |
| White | 76/93 (82%) | 9/87 (10%) | |
| Other | 11/93 (12%) | 8/87 (9.2%) | |
| Ethnicity | .028 | ||
| Not Hispanic | 75/93 (81%) | 80/87 (92%) | |
| Hispanic | 18/93 (19%) | 7/87 (8.0%) | |
| Gender | .014 | ||
| Male | 75/93 (81%) | 56/87 (64%) | |
| Female | 18/93 (19%) | 31/87 (36%) | |
| Sickle hemoglobinopathies | <.001 | ||
| None | 91/91 (100%) | 7/86 (8.1%) | |
| Sickle cell trait | 0/91 (0%) | 76/86 (88.4%) | |
| Sickle cell disease | 0/91 (0%) | 1/86 (1.2%) | |
| Sickle cell beta thalassemia | 0/91 (0%) | 2/86 (2.3%) | |
| Unknown | 0/91 (0%) | 1 |
1Median (range); n/N (%).
2Wilcoxon rank sum test; Pearson’s chi-squared test.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
